Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127173362 | 12717336 | 2 | F | 20160720 | 20160914 | 20160906 | 20160926 | EXP | GB-MHRA-EYC 00144056 | GB-CONCORDIA PHARMACEUTICALS INC.-GSH201608-004309 | CONCORDIA | 72.00 | YR | F | Y | 83.80000 | KG | 20160926 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127173362 | 12717336 | 1 | PS | DIGOXIN. | DIGOXIN | 1 | Oral | RE-INTRODUCED ON 27/07/2016 | D | N | 20405 | QD | |||||||
| 127173362 | 12717336 | 2 | C | ARANESP | DARBEPOETIN ALFA | 1 | 0 | /wk | |||||||||||
| 127173362 | 12717336 | 3 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 0 | 4 | MG | BID | |||||||||
| 127173362 | 12717336 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | 5 | MG | QD | |||||||||
| 127173362 | 12717336 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 60MG IN THE MORNING, 40MG AT LUNCHTIME. | 0 | 100 | MG | |||||||||
| 127173362 | 12717336 | 6 | C | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | 0 | ||||||||||||
| 127173362 | 12717336 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100/125 MICROGRAMS ON ALTERNATIVE DAYS. | 0 | |||||||||||
| 127173362 | 12717336 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | AT NIGHT. | 0 | 20 | MG | QD | ||||||||
| 127173362 | 12717336 | 9 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 400/12. IN THE MORNING. | 0 | 1 | DF | QD | ||||||||
| 127173362 | 12717336 | 10 | C | TERBUTALINE | TERBUTALINE | 1 | 1-2 PUFFS. | 0 | |||||||||||
| 127173362 | 12717336 | 11 | C | WARFARIN | WARFARIN | 1 | AS PER INTERNATIONAL NORMALISED RATIO (INR) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127173362 | 12717336 | 1 | Atrial fibrillation |
| 127173362 | 12717336 | 6 | Diabetes mellitus |
| 127173362 | 12717336 | 7 | Hypothyroidism |
| 127173362 | 12717336 | 9 | Chronic obstructive pulmonary disease |
| 127173362 | 12717336 | 10 | Asthma |
| 127173362 | 12717336 | 11 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127173362 | 12717336 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127173362 | 12717336 | Acute kidney injury | |
| 127173362 | 12717336 | Toxicity to various agents | |
| 127173362 | 12717336 | Ventricular arrhythmia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127173362 | 12717336 | 1 | 20160720 | 0 |